Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The clinical titration starts at 0.25 mg weekly and increases every four weeks up to a maintenance dose of 2.4 mg weekly, though some research protocols extend up to 4.5 mg
Given that there was no difference in total GSH between Preparation Condition 1 and Preparation Condition 2, and that free GSH is significantly higher in Preparation Condition 1 than in Preparation Condition 2, these results suggest that EDTA-treatment more effectively prevents spontaneous oxidation of free GSH in plasma than does heparinization of samples
avoid light exposure For Laboratory Research Use Only Key Characteristics of Epithalon (10mg) Defined, well-characterized tetrapeptide sequence (AEDG) that supports consistent research workflows
Because GHK is a naturally occurring peptide already present in human plasma, serum, saliva, and urine, the body recognizes it as endogenous rather than foreign
